Advertisement

Index by Author

March 1994; 43 (3)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Aguilar-Diosdado, M

    • Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes March 1994 43:418-425; doi:10.2337/diabetes.43.3.418

  2. Ahmad, F

    • Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response. Diabetes March 1994 43:375-383; doi:10.2337/diabetes.43.3.375

  3. Alhenc-Gelas, F

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

  4. Andreani, D

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

B

  1. Bartoli, E

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

  2. Bazzan, M

    • PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes March 1994 43:426-429; doi:10.2337/diabetes.43.3.426

  3. Beckmann, J S

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  4. Bernadet, P

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

  5. Berti, L

    • Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes March 1994 43:447-453; doi:10.2337/diabetes.43.3.447

  6. Bianchi, S

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

  7. Boel, E

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

  8. Born, J

    • Evidence for effects of insulin on sensory processing in humans. Diabetes March 1994 43:351-356; doi:10.2337/diabetes.43.3.351

  9. Boulton, A J

    • Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes March 1994 43:357-368; doi:10.2337/diabetes.43.3.357

  10. Bowsher, R R

    • [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes March 1994 43:396-402; doi:10.2337/diabetes.43.3.396

  11. Brocco, E

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

  12. Brunelle, R L

    • [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes March 1994 43:396-402; doi:10.2337/diabetes.43.3.396

C

  1. Cambien, F

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

  2. Casini, A

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

  3. Cavallo-Perin, P

    • PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes March 1994 43:426-429; doi:10.2337/diabetes.43.3.426

  4. Ceriello, A

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

  5. Chavers, B M

    • Relationship between retinal and glomerular lesions in IDDM patients. Diabetes March 1994 43:441-446; doi:10.2337/diabetes.43.3.441

  6. Cheung, E

    • Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes March 1994 43:403-410; doi:10.2337/diabetes.43.3.403

  7. Christianson, G J

    • Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes March 1994 43:505-509; doi:10.2337/diabetes.43.3.505

  8. Cipollina, M R

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

  9. Corbett, J A

    • Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes March 1994 43:418-425; doi:10.2337/diabetes.43.3.418

  10. Crepaldi, G

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

D

  1. Deragon, G

    • Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response. Diabetes March 1994 43:375-383; doi:10.2337/diabetes.43.3.375

  2. De Riva, F

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

  3. De Stasio, G

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

  4. Detheux, M

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  5. Dyrberg, T

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

E

  1. Espinosa, R, 3rd

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

F

  1. Falleti, E

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

  2. Fantus, I G

    • Vanadate augments insulin-stimulated insulin receptor kinase activity and prolongs insulin action in rat adipocytes. Evidence for transduction of amplitude of signaling into duration of response. Diabetes March 1994 43:375-383; doi:10.2337/diabetes.43.3.375

  3. Fehm, H L

    • Evidence for effects of insulin on sensory processing in humans. Diabetes March 1994 43:351-356; doi:10.2337/diabetes.43.3.351

  4. Fischer, J S

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

  5. Fischer, P A

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

  6. Friedman, H

    • Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes March 1994 43:433-440; doi:10.2337/diabetes.43.3.433

  7. Frigato, F

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

G

  1. Galli, G

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

  2. Gallois, Y

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

  3. Gerling, I C

    • Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes March 1994 43:433-440; doi:10.2337/diabetes.43.3.433

  4. Giacomello, R

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

  5. Gingerich, R L

    • Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes March 1994 43:418-425; doi:10.2337/diabetes.43.3.418

  6. Gonano, F

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

  7. Greiner, D

    • Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes March 1994 43:505-509; doi:10.2337/diabetes.43.3.505

  8. Greiner, D L

    • Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes March 1994 43:433-440; doi:10.2337/diabetes.43.3.433

  9. Gruden, G

    • PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes March 1994 43:426-429; doi:10.2337/diabetes.43.3.426

  10. Guler, H P

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

  11. Guyene, T T

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

H

  1. Hallab, M

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

  2. Häring, H

    • Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes March 1994 43:447-453; doi:10.2337/diabetes.43.3.447

  3. Hejnaes, K R

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

  4. Hoffman, R G

    • Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity. Diabetes March 1994 43:468-477; doi:10.2337/diabetes.43.3.468

  5. Howey, D C

    • [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes March 1994 43:396-402; doi:10.2337/diabetes.43.3.396

  6. Høier-Madsen, M

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

J

  1. Jabri, N

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

  2. Jaenisch, R

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

  3. Jansson, L

    • Pancreatic islet blood flow in the rat after administration of islet amyloid polypeptide or calcitonin gene-related peptide. Diabetes March 1994 43:454-458; doi:10.2337/diabetes.43.3.454

K

  1. Karhapää, P

    • Isolated low HDL cholesterol. An insulin-resistant state. Diabetes March 1994 43:411-417; doi:10.2337/diabetes.43.3.411

  2. Karlsen, A E

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

  3. Kellerer, M

    • Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes March 1994 43:447-453; doi:10.2337/diabetes.43.3.447

  4. Kerner, W

    • Evidence for effects of insulin on sensory processing in humans. Diabetes March 1994 43:351-356; doi:10.2337/diabetes.43.3.351

  5. Kern, W

    • Evidence for effects of insulin on sensory processing in humans. Diabetes March 1994 43:351-356; doi:10.2337/diabetes.43.3.351

  6. Kiehn, R

    • Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes March 1994 43:447-453; doi:10.2337/diabetes.43.3.447

  7. Kipnes, M S

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

  8. Kissebah, A H

    • Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity. Diabetes March 1994 43:468-477; doi:10.2337/diabetes.43.3.468

  9. Kroder, G

    • Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes March 1994 43:447-453; doi:10.2337/diabetes.43.3.447

  10. Krook, A

    • Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes March 1994 43:357-368; doi:10.2337/diabetes.43.3.357

  11. Kumar, S

    • Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes March 1994 43:357-368; doi:10.2337/diabetes.43.3.357

  12. Kwon, G

    • Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes March 1994 43:418-425; doi:10.2337/diabetes.43.3.418

L

  1. Laakso, M

    • Isolated low HDL cholesterol. An insulin-resistant state. Diabetes March 1994 43:411-417; doi:10.2337/diabetes.43.3.411

  2. Laing, I

    • Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes March 1994 43:357-368; doi:10.2337/diabetes.43.3.357

  3. Lebeau, M M

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  4. Lehto, M

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  5. Leiter, E H

    • Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes March 1994 43:433-440; doi:10.2337/diabetes.43.3.433
    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500
    • Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes March 1994 43:505-509; doi:10.2337/diabetes.43.3.505

  6. Lenti, L

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

  7. Lizzio, S

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

M

  1. Malkki, M

    • Isolated low HDL cholesterol. An insulin-resistant state. Diabetes March 1994 43:411-417; doi:10.2337/diabetes.43.3.411

  2. Marcsisin, V S

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

  3. Marre, M

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

  4. Marshall, C A

    • Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes March 1994 43:418-425; doi:10.2337/diabetes.43.3.418

  5. Marshall, M O

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

  6. Mauer, S M

    • Relationship between retinal and glomerular lesions in IDDM patients. Diabetes March 1994 43:441-446; doi:10.2337/diabetes.43.3.441

  7. McDaniel, M L

    • Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes March 1994 43:418-425; doi:10.2337/diabetes.43.3.418

  8. Meneilly, G S

    • Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes March 1994 43:403-410; doi:10.2337/diabetes.43.3.403

  9. Mene, P

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

  10. Michelsen, B K

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

  11. Moody, A

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

  12. Mosthaf, L

    • Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes March 1994 43:447-453; doi:10.2337/diabetes.43.3.447

  13. Motz, E

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

  14. Mueller, R A

    • Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity. Diabetes March 1994 43:468-477; doi:10.2337/diabetes.43.3.468

  15. Muollo, B

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

N

  1. Newgard, C B

    • Cellular engineering and gene therapy strategies for insulin replacement in diabetes. Diabetes March 1994 43:341-350; doi:10.2337/diabetes.43.3.341

  2. Nosadini, R

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

O

  1. O'Rahilly, S

    • Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes March 1994 43:357-368; doi:10.2337/diabetes.43.3.357

P

  1. Pagano, G

    • PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes March 1994 43:426-429; doi:10.2337/diabetes.43.3.426

  2. Parkinson, D

    • Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes March 1994 43:418-425; doi:10.2337/diabetes.43.3.418

  3. Passa, P

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

  4. Petersen, J S

    • Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes March 1994 43:459-467; doi:10.2337/diabetes.43.3.459

  5. Peterson, E

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

  6. Peterson, L B

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

  7. Pietrowsky, R

    • Evidence for effects of insulin on sensory processing in humans. Diabetes March 1994 43:351-356; doi:10.2337/diabetes.43.3.351

  8. Podolin, P L

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

  9. Pricci, F

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

  10. Pugliese, F

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

  11. Pugliese, G

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

R

  1. Radnik, B J

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

  2. Ramsay, R C

    • Relationship between retinal and glomerular lesions in IDDM patients. Diabetes March 1994 43:441-446; doi:10.2337/diabetes.43.3.441

  3. Renjilian, R J

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

  4. Roopenian, D C

    • Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes March 1994 43:505-509; doi:10.2337/diabetes.43.3.505

  5. Rotella, C M

    • Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes March 1994 43:478-490; doi:10.2337/diabetes.43.3.478

S

  1. Sambataro, M

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

  2. Sandler, S

    • Pancreatic islet blood flow in the rat after administration of islet amyloid polypeptide or calcitonin gene-related peptide. Diabetes March 1994 43:454-458; doi:10.2337/diabetes.43.3.454

  3. Santiago, J V

    • Potential autoantigens in IDDM. Expression of carboxypeptidase-H and insulin but not glutamate decarboxylase on the beta-cell surface. Diabetes March 1994 43:418-425; doi:10.2337/diabetes.43.3.418

  4. Savagner, F

    • Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes March 1994 43:384-388; doi:10.2337/diabetes.43.3.384

  5. Schalch, D S

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

  6. Schlosser, C

    • Evidence for effects of insulin on sensory processing in humans. Diabetes March 1994 43:351-356; doi:10.2337/diabetes.43.3.351

  7. Schwartz, S L

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

  8. Serreze, D V

    • Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes March 1994 43:505-509; doi:10.2337/diabetes.43.3.505

  9. Shultz, L D

    • Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes March 1994 43:433-440; doi:10.2337/diabetes.43.3.433

  10. Solini, A

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

  11. Sonnenberg, G E

    • Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity. Diabetes March 1994 43:468-477; doi:10.2337/diabetes.43.3.468

  12. Steffes, M W

    • Relationship between retinal and glomerular lesions in IDDM patients. Diabetes March 1994 43:441-446; doi:10.2337/diabetes.43.3.441

  13. Stella, S

    • PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes March 1994 43:426-429; doi:10.2337/diabetes.43.3.426

  14. Stoffel, M

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  15. Sun, F

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  16. Svensson, A M

    • Pancreatic islet blood flow in the rat after administration of islet amyloid polypeptide or calcitonin gene-related peptide. Diabetes March 1994 43:454-458; doi:10.2337/diabetes.43.3.454

T

  1. Taboga, C

    • Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes March 1994 43:430-432; doi:10.2337/diabetes.43.3.430

  2. Tippmer, S

    • Troglitazone prevents glucose-induced insulin resistance of insulin receptor in rat-1 fibroblasts. Diabetes March 1994 43:447-453; doi:10.2337/diabetes.43.3.447

  3. Todd, J A

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

  4. Tuokko, H

    • Counterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes. Diabetes March 1994 43:403-410; doi:10.2337/diabetes.43.3.403

  5. Turman, N J

    • Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. Diabetes March 1994 43:369-374; doi:10.2337/diabetes.43.3.369

V

  1. Vaxillaire, M

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  2. Velussi, M

    • Impaired insulin-induced glucose uptake by extrahepatic tissue is hallmark of NIDDM patients who have or will develop hypertension and microalbuminuria. Diabetes March 1994 43:491-499; doi:10.2337/diabetes.43.3.491

  3. Vigouroux, C

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  4. Vionnet, N

    • Search for a third susceptibility gene for maturity-onset diabetes of the young. Studies with eleven candidate genes. Diabetes March 1994 43:389-395; doi:10.2337/diabetes.43.3.389

  5. Vuolo, A

    • PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes March 1994 43:426-429; doi:10.2337/diabetes.43.3.426

W

  1. Wass, J A

    • Molecular scanning of the insulin receptor gene in syndromes of insulin resistance. Diabetes March 1994 43:357-368; doi:10.2337/diabetes.43.3.357

  2. Wicker, L S

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

  3. Woodworth, J R

    • [Lys(B28), Pro(B29)]-human insulin. A rapidly absorbed analogue of human insulin. Diabetes March 1994 43:396-402; doi:10.2337/diabetes.43.3.396

Z

  1. Zijlstra, M

    • Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes March 1994 43:500-504; doi:10.2337/diabetes.43.3.500

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement